ESTABLISHED STERILE COMPOUNDING PHARMACY - 503A LICENSED FACILITY
This turnkey pharmaceutical operation represents a premium acquisition opportunity in the rapidly expanding specialty compounding sector. The facility operates as a fully licensed 503A sterile compounding pharmacy with comprehensive regulatory compliance and established market presence.

KEY OPERATIONAL HIGHLIGHTS:
• Multi-state licensing platform with 17 active state pharmaceutical licenses
• Specialized focus on sterile compounding with GLP-1 product capabilities
• All-cash revenue model with no PBM dependencies
• GLP-1 products represent 30% of current sales volume
• Established customer base with documented revenue history
• Stand-alone pharmaceutical facility included in acquisition

FACILITY & INFRASTRUCTURE:
• Purpose-built sterile compounding facility
• Real estate included in transaction package
• Compliant clean room environments and specialized equipment
• Strategic Houston metropolitan location

GROWTH POTENTIAL:
• Seller committed to facilitating 503B conversion post-acquisition
• Access to proprietary next-generation product development opportunities
• Expanding GLP-1 market segment with significant growth trajectory
• Established regulatory framework supporting operational scalability

OWNERSHIP STRUCTURE:
• Current owner seeking to retain 10%-50% equity participation
• Demonstrates confidence in continued business performance
• Opportunity for strategic partnership with experienced operator

FINANCIAL REQUIREMENTS:
• Investment opportunity: $7,900,000
• All-cash transaction structure
• Proof of funds verification required for qualification
• Working capital requirements must be demonstrated

This acquisition presents an exceptional opportunity to enter the high-growth specialty pharmaceutical compounding sector with an established, compliant operation positioned for immediate productivity and long-term expansion.